OLANZAPINE 10 MG VIAL
For 1 unit (EA)
Pharmacies pay
$20.92 filed
1 × $20.923 per EA
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part B pays
$12.30 derived
1 × $12.30 per EA, Part B limit
Medicare's price is not your price.
OpenBill calculation · october-2026-medicare-part-b-payment-limit-files-final.zip + october-2026-ndc-hcpcs-crosswalk-final.zip · Part B limit 2026-10-01 to 2026-12-31 (file of 2026-09-17, retrieved 2026-10-18) · Part B crosswalk 2026-10-01 to 2026-12-31 (file of 2026-09-17, retrieved 2026-10-18)
The spread
0.59× estimated
Medicare pays 41% less than pharmacies pay.
8 labelers share HCPCS J2359 on the CMS crosswalk, so its payment limit is an average across all their products billed under that code, not this NDC’s own price.
OpenBill calculation · october-2026-medicare-part-b-payment-limit-files-final.zip + october-2026-ndc-hcpcs-crosswalk-final.zip + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part B limit 2026-10-01 to 2026-12-31 (file of 2026-09-17, retrieved 2026-10-18) · Part B crosswalk 2026-10-01 to 2026-12-31 (file of 2026-09-17, retrieved 2026-10-18)
Cost-plus estimate
$29.06 estimated
$20.92 + $3.14 (15%) + $5.00 fee per fill = $29.06
This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out
OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)
Open the interactive card Change the quantity, type what you were charged, and see every record in full.
What it is
OLANZAPINE 10 MG VIAL is how the CMS NADAC file names this product. The FDA NDC Directory lists it as olanzapine, under the trade name “Olanzapine Intramuscular”.
FDA gives its dosage form as “injection, powder, for solution” and “injection, powder, lyophilized, for solution” and its route as intramuscular.
FDA lists 9 labelers (the companies named on the label) for its NDCs, among them PAI Holdings, LLC dba PAI Pharma, Hikma Pharmaceuticals USA Inc. and American Regent, Inc.
FDA’s Established Pharmacologic Class for it is Atypical Antipsychotic.
The NADAC file of 2026-10-14 prices it under 10 NDCs (National Drug Codes).
NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.
What pharmacies pay
Pharmacies pay $20.92 for 1 unit (EA) (1 × $20.923 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.
NADAC’s explanation codes for it: 1, calculated from the most recently completed pharmacy survey; 5, calculated based on package size.
What NADAC measures · NADAC explanation codes
The 9 labelers
| Labeler | NDCs | Pharmacies pay per unit |
|---|---|---|
| Sandoz Inc | 2 | $20.923 per EA filed |
| American Regent, Inc. | 1 | $20.923 per EA filed |
| Camber Pharmaceuticals, Inc. | 1 | $20.923 per EA filed |
| Eugia US LLC | 1 | $20.923 per EA filed |
| GLENMARK PHARMACEUTICALS INC., USA | 1 | $20.923 per EA filed |
| Hikma Pharmaceuticals USA Inc. | 1 | $20.923 per EA filed |
| NorthStar RxLLC | 1 | $20.923 per EA filed |
| PAI Holdings, LLC dba PAI Pharma | 1 | $20.923 per EA filed |
| XGen Pharmaceuticals DJB, Inc. | 1 | $20.923 per EA filed |
All 10 NDCs, with labeler and price
- 00121-1072-55 · PAI Holdings, LLC dba PAI Pharma · $20.923 per EA · eff. 2026-09-23 filed
- 00143-9199-01 · Hikma Pharmaceuticals USA Inc. · $20.923 per EA · eff. 2026-09-23 filed
- 00517-0955-01 · American Regent, Inc. · $20.923 per EA · eff. 2026-09-23 filed
- 00781-3159-72 · Sandoz Inc · $20.923 per EA · eff. 2026-09-23 filed
- 00781-9105-72 · Sandoz Inc · $20.923 per EA · eff. 2026-09-23 filed
- 31722-0308-01 · Camber Pharmaceuticals, Inc. · $20.923 per EA · eff. 2026-09-23 filed
- 39822-1800-01 · XGen Pharmaceuticals DJB, Inc. · $20.923 per EA · eff. 2026-09-23 filed
- 55150-0308-01 · Eugia US LLC · $20.923 per EA · eff. 2026-09-23 filed
- 68462-0952-10 · GLENMARK PHARMACEUTICALS INC., USA · $20.923 per EA · eff. 2026-09-23 filed
- 72603-0181-01 · NorthStar RxLLC · $20.923 per EA · eff. 2026-09-23 filed
Other strengths, forms and brands
12 other products in the NADAC file share the FDA nonproprietary name olanzapine with OLANZAPINE 10 MG VIAL.
| Product | Pharmacies pay per unit | Medicare per unit |
|---|---|---|
| OLANZAPINE 2.5 MG TABLET | $0.08111 per EA filed | $0.69617 per EA filed |
| OLANZAPINE 5 MG TABLET | $0.08709 per EA filed | $0.69617 per EA filed |
| OLANZAPINE 7.5 MG TABLET | $0.09436 per EA filed | $0.69617 per EA filed |
| OLANZAPINE 10 MG TABLET | $0.10905 per EA filed | $0.69617 per EA filed |
| OLANZAPINE 10 MG VIAL this page | $20.923 per EA filed | $12.30 per EA derived |
| OLANZAPINE 15 MG TABLET | $0.13454 per EA filed | $0.69617 per EA filed |
| OLANZAPINE 20 MG TABLET | $0.14674 per EA filed | $0.69617 per EA filed |
| OLANZAPINE ODT 5 MG TABLET | $0.30355 per EA filed | $2.32626 per EA filed |
| OLANZAPINE ODT 10 MG TABLET | $0.36633 per EA filed | $2.32626 per EA filed |
| OLANZAPINE ODT 15 MG TABLET | $0.63877 per EA filed | $2.32626 per EA filed |
| OLANZAPINE ODT 20 MG TABLET | $0.72217 per EA filed | $2.32626 per EA filed |
| ZYPREXA 5 MG TABLET | $16.61576 per EA filed | $29.02717 per EA filed |
| ZYPREXA 20 MG TABLET | $49.88179 per EA filed | $29.02717 per EA filed |
Part D is one average per brand and generic name, over every strength and form.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
OpenBill calculation · october-2026-medicare-part-b-payment-limit-files-final.zip + october-2026-ndc-hcpcs-crosswalk-final.zip · Part B limit 2026-10-01 to 2026-12-31 (file of 2026-09-17, retrieved 2026-10-18) · Part B crosswalk 2026-10-01 to 2026-12-31 (file of 2026-09-17, retrieved 2026-10-18)
Compared with its class
The middle of its 10 NDCs’ NADAC prices is $20.923 per EA filed.
Of the 130 other products in FDA’s Atypical Antipsychotic class priced per EA, 45 have a higher middle NADAC price and 85 a lower one. The one in the middle is OLANZAPINE-FLUOXETINE 6-25 MG, at $4.05968 per EA filed (eff. 2026-09-23).
Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
What Medicare paid
Medicare Part B’s payment limit for HCPCS J2359, for 2026-10-01 to 2026-12-31, comes to $12.30 for 1 unit (EA), or $12.30 per EA once converted to NADAC’s unit for this product.
Medicare Part B pays for a drug like this only in specific settings, such as a drug given in a clinic or doctor’s office or used with certain medical equipment; most prescriptions filled at a pharmacy are paid by Part D.
The patient’s share under Part B (coinsurance, 20% of the limit, before deductibles and other coverage) is $0.123 per 0.5 MG.
9 of the product’s 10 NDCs have this Medicare figure; the other 1 do not, and the interactive card says why for each.
Medicare's price is not your price.
What the Part B payment limit is · Converting it to the NADAC unit · How the spread is worked out
What to ask at the counter
None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.
- What is your cash price for 1 unit (EA)? Is it lower than what I would pay through my insurance?
- If you have Medicare Part B: is this drug covered for me in this setting, and what is my share?
- These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.
Questions
- Why does this page start at 1 unit (EA)?
- NADAC prices this product per EA, and the FDA NDC Directory lists its 10 NDCs as dosage forms “INJECTION, POWDER, FOR SOLUTION”, “INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION” with route “INTRAMUSCULAR”. Only a tablet, capsule, lozenge or troche with route “ORAL”, or a tablet or film with route “SUBLINGUAL” or “BUCCAL”, starts at 30, and none of these is one. NADAC’s EA for it may be a whole package (such as a kit, pen, syringe, vial or inhaler) or one dose inside it, and the files do not say which. So the card starts at 1 unit (EA) rather than guess how many make up a fill; change it to match your prescription.
Related pages
Its pharmacologic class
Related in the same class
- QUETIAPINE 150 MG TABLET
- ARIPIPRAZOLE 10 MG TABLET
- RISPERIDONE 0.25 MG TABLET
- CLOZAPINE 100 MG TABLET
- LURASIDONE HCL 120 MG TABLET